Home/Pipeline/SOLIUS Phototherapy System

SOLIUS Phototherapy System

Stimulation of endogenous vitamin D production

CommercialActive

Key Facts

Indication
Stimulation of endogenous vitamin D production
Phase
Commercial
Status
Active
Company

About Solius

Solius operates at the intersection of digital health, metabolic health, and medical devices, offering a novel phototherapy platform. The company's core proposition is that controlled, specific-wavelength light can safely trigger the body's natural production of vitamin D, positioning it as a potential alternative to supplements and sun exposure for addressing widespread vitamin D deficiency. While its devices appear to be commercialized, the company's go-to-market strategy and clinical validation efforts are focused on building a body of research linking vitamin D to a broad range of health conditions. Solius represents a specialized play in the growing light therapy and wellness technology market.

View full company profile